Aspirin desensitization in patients with AERD
- Donald D. Stevenson
- … show all 1 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
All patients with aspirin exacerbated respiratory disease (AERD) can be desensitized to ASA. After achieving this state, patients can then take ASA daily without adverse effect. ASA desensitization can be maintained indefinitely as long as the patient takes ASA each day. Crossdesensitization with older NSAIDs also occurs. After ASA desensitization, patients can take daily ASA in order to treat their underlying respiratory disease. In AERD patients treated with ASA 650 BID for at least a year, 115/172 (67%) improved in their clinical courses while decreasing systemic and topical corticosteroids. Sixteen failed to improve, 24 stopped ASA because of intractable side effects (gastritis or hives) and 17 patients discontinued ASA treatment in the first year of study for unrelated reasons. Therefore, treatment with daily ASA is a significant therapeutic option for patients afflicted with AERD. It should be used for AERD patients who do not respond to topical corticosteroids and leukotriene modifier drugs. Those who respond to systemic steroids or have intractable or recurrent nasal polyps are particularly well-suited for this therapeutic intervention.
- Stevenson, D., Sánchez-Borges, M., and Szczeklik, A. (2001), Classification of allergic and pseudo-allergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann. Allergy Asthma Immunol. 87, 177–180. CrossRef
- Stevenson, D., and Simon, R. A. Sensitivity to aspirin and nonsteroidal antiinflammatory drugs, in Allergy: Principles and Practice. Middleton, Jr., E., Ellis, E. F., Yunginger, J. W., Reed, C. E., Adkinson, N. F., Jr., and Busse, W. W., eds., vol. 2, 5th ed. Mosby, St. Louis, 1998, pp. 1225–1234.
- Zeiss, C. R., and Lockey, R. F. (1976), Refractory period to aspirin in a patient with aspirin-induced asthma. J. Allergy Clin. Immunol. 57, 440–448. CrossRef
- Bianco, S. R. M., and Petrini, G. (1977), Aspirin induced tolerance in aspirin-asthma detected by a new challenge test. IRCS J. Med. Sci. 5, 129–136.
- Stevenson, D. D., Simon, R. A., and Mathison, D. A. (1980), Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J. Allergy Clin. Immunol. 66, 82–88. CrossRef
- Pleskow, W. W., Stevenson, D. D., Mathison, D. A., Simon, R. A., Schatz, M., and Zieger, R. S. (1982), Aspirin desensitization in aspirin sensitive asthmatic patients: clinical and manifestations and characterization of the refractory period. J. Allergy Clin. Immunol. 69, 11–19. CrossRef
- Stevenson, D. (1999), Oral desensitization to aspirin. AIANE 1–4.
- Stevenson, D. D. Drug-induced asthma, in Asthma, Slavin, R. and Reisman, R. E., eds., vol. 1. American College of Physicians, Philadelphia, 2002, pp. 191–208.
- Chiu, J. T. (1983), Improvement in aspirin-sensitive asthmatic subjects after rapid aspirin desensitization and aspirin maintenance (ADAM) treatment. J. Allergy Clin. Immunol. 71(6), 560–567. CrossRef
- Lumry, W. R., Curd, J. G., Zieger, R. S., Pleskow, W. W., and Stevenson, D. D. (1983), Aspirin-sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration. J. Allergy Clin. Immunol. 71, 580–587. CrossRef
- Stevenson, D. D., Pleskow, W. W., Simon, R. A., Mathison, D. A., Lumry, W. R., Schatz, M., et al. (1984), Aspirin-sensitive rhinosinusitis asthma: a double-blind cross-over study of treatment with aspirin. J. Allergy Clin. Immunol. 73, 500–507. CrossRef
- Nelson, R. P., Stablein, J. J., and Lockey, R. F. (1986), Asthma improved by acetylsalicylic acid and other nonsteroidal anti-inflammatory agents. N. Engl. Reg. Allergy Proc. 7, 117–121. CrossRef
- Kowalski, M., Grzelewska-Rzymowska, I., Szmidt, M., and Rozniecki, J. (1986), Clinical efficacy of aspirin in “desensitized” aspirin-sensitive asthmatics. Eur. J. Respir. Dis. 69, 219–225.
- Sweet, J. A., Stevenson, D. D., Simon, R. A., and Mathison, D. A. (1990), Long term effects of aspirin desensitization treatment for aspirin sensitive rhinosinusitis asthma. J. Allergy Clin. Immunol. 86, 59–65. CrossRef
- Stevenson, D. D., Hankammer, M. A., Mathison, D. A., Christensen, S. C., and Simon, R. A. (1996), Long term ASA desensitization-treatment of aspirin sensitive asthmatic patients: clinical outcome studies. J. Allergy Clin. Immunol. 98, 751–758. CrossRef
- Naeije, N., Bracamonte, M., Michel, O., et al. (1984), Effects of chronic aspirin ingestion in aspirin-intolerant asthmatic patients. Ann. Allergy 53, 262–264.
- Berges-Gimeno, M. P., Simon, R. A., and Stevenson, D. D. (2003) Treatment with aspirin desensitization in aspirin exacerbated respiratory disease. J. Allergy Clin. Immunol. (Accepted for publication.)
- Aspirin desensitization in patients with AERD
Clinical Reviews in Allergy & Immunology
Volume 24, Issue 2 , pp 159-167
- Cover Date
- Print ISSN
- Online ISSN
- Humana Press
- Additional Links
- Aspirin (ASA)
- nonsteroidal antiinflammatory drug (NSAID)
- aspirin-exacerbated respiratory disease (AERD)
- general clinical research center (GCRC)
- Industry Sectors
- Author Affiliations
- 1. Division of Allergy, Asthma, and Immunology, Scripps Clinic and the Scripps Research Institute, 10666 North Torrey Pines Road, 92037, La Jolla, CA